Mindblown: a blog about philosophy.
-
Thyroid Eye Disease Market Set to Witness Growth with Rising Awareness, Early Diagnosis, and Emerging Targeted Therapies by 2034 – DelveInsight | Immunovant Sciences, Viridian Therapeutics, Novartis
The Key Thyroid Eye Disease Companies in the market include – Horizon Therapeutics, Immunovant Sciences, Viridian Therapeutics, Novartis Pharmaceuticals, Sling Therapeutics, Regeneron Pharmaceuticals, ValenzaBio, and others. (Albany, US), October 08, 2026 – DelveInsight’s report “Thyroid Eye Disease Market Insights, Epidemiology, and Market Forecast – 2034” delivers an in-depth understanding of thyroid eye disease, presenting historical…
-
Anesthesia Machines Market to Reach USD 34.40 Billion by 2034, Driven by Rising Surgical Volumes, Ambulatory Surgical Center Expansion, and AI-Enabled Anesthesia Platforms
Key Anesthesia Machines companies such as Shenzhen Comen Medical Instruments Co., Ltd., SternMed GmbH, General Electric Company, Koninklijke Philips N.V., Drägerwerk AG & Co. KgaA, Mindray DS USA, Inc., Heal Force, Northern Meditec Limited, Shanghai Huifeng Medical Instrument, RWD Life Science Co. Ltd., and others. (Albany, US), October 08, 2026 – DelveInsight’s “Anesthesia Machines Market”…
-
Congenital Hyperinsulinism Market to Grow at 12% CAGR Through 2036, Driven by Advancements in Targeted Therapies and Increasing Diagnosis | DelveInsight
The market dynamics for Congenital Hyperinsulinism (CHI) are witnessing significant growth, driven by increasing disease awareness, advancements in genetic testing, improvements in neonatal diagnosis, and growing demand for effective treatments for persistent hypoglycemia. The therapeutic landscape is gradually evolving from conventional glucose management and insulin-suppressing medications toward targeted approaches designed to address abnormal insulin signaling.…
-
Hereditary Transthyretin Amyloidosis Market is Projected to Reach USD 3 Billion by 2025 and Grow at 11% CAGR Through 2036 Owing to Advancements in RNA-based and Gene-Editing Therapies | DelveInsight
The market dynamics for Hereditary Transthyretin Amyloidosis (hATTR) are witnessing robust growth driven by increasing disease awareness, improvements in genetic testing and diagnosis, advancements in RNA-based gene-silencing therapies, and growing adoption of disease-modifying treatments. (Albany, New York) – October 08, 2026 – The market dynamics for Hereditary Transthyretin Amyloidosis (hATTR) are witnessing robust growth driven…
-
Portable Ultrasound Bladder Scanner Market to Grow from USD 278.13 Million at a CAGR of 3.80% Through 2032Portable Ultrasound Bladder Scanner Market
(Albany, New York) – October 08, 2026 – DelveInsight’s “Portable Ultrasound Bladder Scanner Market” report offers an in-depth understanding of the global portable ultrasound bladder scanner industry, covering market size, segmentation trends, regional dynamics, and competitive landscape through 2032. To know in detail about the portable ultrasound bladder scanner market outlook, segment-wise trends, and regional analysis…
-
Neuropathic Pain Market Poised for Major Change Through 2032 as Pipeline Therapies Advance
According to DelveInsight, the Neuropathic Pain market in the 7MM is expected to witness a major change during the study period 2019–2032, driven by rising awareness of the disease and incremental healthcare spending across the world, which would expand the size of the market and enable drug manufacturers to penetrate further. (Albany, New York) –…
-
HPV Testing and Pap Test Market to Reach USD 6,524.39 Million by 2034, Driven by Rising Cervical Cancer Cases, Government Screening Programs, and Molecular Diagnostic Advancements
Key HPV Testing and Pap Test companies such as F. Hoffmann-La Roche, Hologic Inc., Becton Dickinson, QIAGEN, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Seegene Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Femasys Inc., Arbor Vita Corporation, Quest Diagnostics, LabCorp, Sysmex Corporation, FUJIFILM Holdings, Olympus Corporation, CooperSurgical, Cardinal Health, Nihon Kohden, and others. (Albany, New York) –…
-
Prurigo Nodularis Market to Reach USD 4,433 Million by 2034, Driven by Rising Disease Prevalence, Novel Drug Approvals, and a Robust Emerging Therapy Pipeline
Key Prurigo Nodularis companies such as Sanofi, Regeneron, Galderma, Maruho, Amgen/Kyowa Kirin, Incyte Corporation, Keymed Biosciences, Celldex Therapeutics, and others. (Albany, New York) – October 08, 2026 – DelveInsight’s “Prurigo Nodularis Market Insight, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of prurigo nodularis, historical and forecasted epidemiology, as well as the prurigo…
-
Transcatheter Aortic Valve Replacement Market Set to Reach USD 7.64 Billion by 2032
DelveInsight’s latest market analysis reports that the Global Transcatheter Aortic Valve Replacement (TAVR) Devices Market was valued at USD 3.23 billion in 2024 and is projected to reach USD 7.64 billion by 2032, growing at a CAGR of 15.41% during the forecast period. (Albany, New York) – October 08, 2026 – Global Transcatheter Aortic Valve Replacement…
-
Acute Coronary Syndrome Market is Projected to Reach USD 9 Billion by 2036 Owing to Rising Disease Incidence and Advancements in Targeted Cardiovascular Therapies | DelveInsight
The market dynamics for Acute Coronary Syndrome (ACS) are witnessing significant growth driven by the rising incidence of acute myocardial infarction, an aging population, increasing prevalence of cardiovascular risk factors, and continued advances in antithrombotic, lipid-lowering, and anti-inflammatory therapies. (Albany, New York) – October 08, 2026 – The market dynamics for Acute Coronary Syndrome (ACS)…
Got any book recommendations?